TNDM Stock Analysis: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$22.38
3.59 (19.11%)
▲
5d:
+14.77%
30d:
+45.61%
90d:
+21.17%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TNDM is 17.2% above its trading range ($19.09). Market expects -9.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TNDM is 17.2% above its trading range ($19.09). Market expects -9.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $22.38, which is considered extended relative to its 30-day fair value range of $15.33 to $19.09. From a valuation perspective, the stock is trading at a discount (Forward PE: 176.1) compared to its historical average (235.7). Remarkably, the market is currently pricing in an annual earnings decline of 9.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is approaching resistance at $22.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 19.1% recently.
Market Sentiment: TNDM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.52 (+51.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is approaching resistance at $22.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 19.1% recently.
Market Sentiment: TNDM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.52 (+51.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$15.33 -
$19.09
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
TNDM is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+17.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+19.1%)
- BULLISH: Trading 51.8% below Wall St target ($28.52)
- WARNING: Recommendation downgraded due to 17.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$15.33 -
$19.09
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.34
Resistance Level
$22.65
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
176.10
Wall Street Target
$28.53
(+51.8%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
-37.0%
Profit Margin
-9.2%
Valuation Discount vs History
-9.3% cheaper
PE vs Historical
176.1 vs 235.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.3%
(market-implied from PE analysis)
1-Year Target
$17.04
(-9%)
2-Year Target
$15.46
(-18%)
3-Year Target
$14.02
(-25%)
3-Yr Target (if PE normalizes)
(PE: 176→236)
$18.76
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 176.1 to 235.7
Stabilization Target:
$25.15
(+33.8%)
PE Expansion Potential:
+33.8%
Share & Embed Analysis
Last updated: August 07, 2026 4:08 PM ET
Data refreshes hourly during market hours. Next update: 5:08 PM
Data refreshes hourly during market hours. Next update: 5:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark David Novara
SELL
187 shares
2026-03-17
Mark David Novara
SELL
2 shares
2026-03-05
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 43 HOLD |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
